Silexon Ai Technology

Silexon has developed a biological discovery engine (BDE), an Artificial Intelligence (AI) powered R&D system that can understand, learn, and execute tasks in a wide range of domains, significantly improving the efficiency of life science research and development (up to 90% or more) and reducing the costs (up to 80%). The BDE platform is composed of multiple major software suites, such as BDE-Bio and BDE-Chem. The BDE-Bio generates professional research review reports on human common diseases and drug targets, biomarkers or metabolites that are important for development of therapeutics or diagnostics. Each of these review reports is a comprehensive analysis of hundreds up to tens of thousands of scientific literatures regarding the specific target, biomarker or metabolite, and facilitates research fund application, scientific research paper drafting and patent filing, etc. The BDE-Chem is used for small molecule design and optimization that will follow different drug discovery strategies including- First in Class (FIC)- Fast Follow-on - Repurposing - Drug Likeness